Literature DB >> 26694588

No association between macrolide treatment in infancy and later pyloric stenosis in Sweden.

Jonas F Ludvigsson1,2, Cecilia Lundholm3, Anne K Örtqvist3, Catarina Almqvist3,4.   

Abstract

Entities:  

Keywords:  Antibiotics; Child; Cohort study; Infant; Macrolides; Pyloric stenosis

Mesh：

Substances：

Year:  2015        PMID： 26694588     DOI： 10.1007/s10654-015-0114-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  6 in total

1.  A quality study of a medical birth registry.

Authors:  S Cnattingius; A Ericson; J Gunnarskog; B Källén
Journal:  Scand J Soc Med       Date:  1990-06

2.  The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.

Authors:  Björn Wettermark; Niklas Hammar; Carl Michael Fored; C MichaelFored; Andrejs Leimanis; Petra Otterblad Olausson; Ulf Bergman; Ingemar Persson; Anders Sundström; Barbro Westerholm; Måns Rosén
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-07       Impact factor: 2.890

3.  Azithromycin in early infancy and pyloric stenosis.

Authors:  Matthew D Eberly; Matilda B Eide; Jennifer L Thompson; Cade M Nylund
Journal:  Pediatrics       Date:  2015-03       Impact factor: 7.124

4.  External review and validation of the Swedish national inpatient register.

Authors:  Jonas F Ludvigsson; Eva Andersson; Anders Ekbom; Maria Feychting; Jeong-Lim Kim; Christina Reuterwall; Mona Heurgren; Petra Otterblad Olausson
Journal:  BMC Public Health       Date:  2011-06-09       Impact factor: 3.295

5.  Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.

Authors:  Marie Lund; Björn Pasternak; Rie B Davidsen; Bjarke Feenstra; Camilla Krogh; Lars J Diaz; Jan Wohlfahrt; Mads Melbye
Journal:  BMJ       Date:  2014-03-11

6.  Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis.

Authors:  Anne K Örtqvist; Cecilia Lundholm; Helle Kieler; Jonas F Ludvigsson; Tove Fall; Weimin Ye; Catarina Almqvist
Journal:  BMJ       Date:  2014-11-28
  6 in total
  7 in total

1.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

Review 2.  Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  Mohammed Abdellatif; Sherief Ghozy; Mohamed Gomaa Kamel; Sameh Samir Elawady; Mohamed Mohy Eldeen Ghorab; Andrew Wassef Attia; Truong Thi Le Huyen; Diep Trong Vien Duy; Kenji Hirayama; Nguyen Tien Huy
Journal:  Eur J Pediatr       Date:  2018-11-23       Impact factor: 3.183

Review 3.  Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.

Authors:  Sriparna Basu; Susan Smith
Journal:  Eur J Pediatr       Date:  2020-10-12       Impact factor: 3.183

4.  Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.

Authors:  Renuka Kapoor; Vijaya Kancherla; Yanyan Cao; Jacob Oleson; Jonathan Suhl; Mark A Canfield; Charlotte M Druschel; Russell S Kirby; Robert E Meyer; Paul A Romitti
Journal:  Birth Defects Res       Date:  2018-12-13       Impact factor: 2.344

5.  The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  Hamdi H Almaramhy; Abdulmohsen H Al-Zalabani
Journal:  Ital J Pediatr       Date:  2019-02-04       Impact factor: 2.638

Review 6.  A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy.

Authors:  Jeffrey A Keelan; Matthew S Payne; Matthew W Kemp; Demelza J Ireland; John P Newnham
Journal:  Front Immunol       Date:  2016-04-01       Impact factor: 7.561

Review 7.  Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.

Authors:  L Murchison; P De Coppi; S Eaton
Journal:  Pediatr Surg Int       Date:  2016-09-21       Impact factor: 1.827
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.